BC Extra | Jun 27, 2019
Financial News

MODAG raises €12M series A to test approach to neurodegeneration

Six years after its formation, neurodegeneration company MODAG hopes to use its new €12 million ($13.7 million) series A round to test its disease-modifying approach to a rare Parkinsonian disorder via the company's first clinical...
Items per page:
1 - 1 of 1